Cargando…

The Use of Palmitoylethanolamide in the Treatment of Long COVID: A Real-Life Retrospective Cohort Study

COVID-19 can cause symptoms that last weeks or months after the infection has gone, with a significant impairment of quality of life. Palmitoylethanolamide (PEA) is a naturally occurring lipid mediator that has an entourage effect on the endocannabinoid system mitigating the cytokine storm. The aim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raciti, Loredana, De Luca, Rosaria, Raciti, Gianfranco, Arcadi, Francesca Antonia, Calabrò, Rocco Salvatore
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326613/ https://www.ncbi.nlm.nih.gov/pubmed/35893119 http://dx.doi.org/10.3390/medsci10030037

Ejemplares similares

Gender and Neurosteroids: Implications for Brain Function, Neuroplasticity and Rehabilitation
por: Raciti, Loredana, et al.
Publicado: (2023)

Neurogenic Dysphagia and Nutrition in Disorder of Consciousness: An Overview with Practical Advices on an “Old” but Still Actual Clinical Problem
por: Raciti, Loredana, et al.
Publicado: (2022)

Sleep in Disorders of Consciousness: A Brief Overview on a Still under Investigated Issue
por: Raciti, Loredana, et al.
Publicado: (2023)

Can volcanic trace elements facilitate Covid-19 diffusion? A hypothesis stemming from the Mount Etna area, Sicily
por: Raciti, Loredana, et al.
Publicado: (2020)

Neurological complications of COVID-19: from pathophysiology to rehabilitation. An overview
por: Raciti, Loredana, et al.
Publicado: (2021)

Behavioral and Psychiatric Symptoms in Patients with Severe Traumatic Brain Injury: A Comprehensive Overview
por: Torregrossa, William, et al.
Publicado: (2023)

Nursing, Caregiving and Psychological support in Chronic Disorders of Consciousness: a scoping review
por: Raciti, Loredana, et al.
Publicado: (2021)

Sexual Dysfunctions in Females with Parkinson’s Disease: A Cross-Sectional Study with a Psycho-Endocrinological Perspective
por: De Luca, Rosaria, et al.
Publicado: (2023)

Improving Upper Extremity Bradykinesia in Parkinson’s Disease: A Randomized Clinical Trial on the Use of Gravity-Supporting Exoskeletons
por: Raciti, Loredana, et al.
Publicado: (2022)

Cutting the First Turf to Heal Post-SSRI Sexual Dysfunction: A Male Retrospective Cohort Study
por: De Luca, Rosaria, et al.
Publicado: (2022)

Palmitoylethanolamide in Fibromyalgia: Results from Prospective and Retrospective Observational Studies
por: Del Giorno, Rosaria, et al.
Publicado: (2015)

Cervical Artery Dissection and Patent Foramen Ovale in Juvenile Stroke: Causality or Casuality? A Familiar Case Report
por: Arcadi, Francesca Antonia, et al.
Publicado: (2023)

Psychological and Cognitive Effects of Long COVID: A Narrative Review Focusing on the Assessment and Rehabilitative Approach
por: De Luca, Rosaria, et al.
Publicado: (2022)

Delay of Morphine Tolerance by Palmitoylethanolamide
por: Di Cesare Mannelli, Lorenzo, et al.
Publicado: (2015)

Antioxidant and Anti-Inflammatory Activity of Combined Phycocyanin and Palmitoylethanolamide in Human Lung and Prostate Epithelial Cells
por: Bergandi, Loredana, et al.
Publicado: (2022)

Effect of ultramicronized-palmitoylethanolamide and co-micronized palmitoylethanolamide/polydatin on chronic pelvic pain and quality of life in endometriosis patients: An open-label pilot study
por: Stochino Loi, Emanuela, et al.
Publicado: (2019)

Micronized Palmitoylethanolamide Reduces the Symptoms of Neuropathic Pain in Diabetic Patients
por: Schifilliti, Chiara, et al.
Publicado: (2014)

The Basal Pharmacology of Palmitoylethanolamide
por: Rankin, Linda, et al.
Publicado: (2020)

What Is the Role of Palmitoylethanolamide Co-Ultramicronized with Luteolin on the Symptomatology Reported by Patients Suffering from Long COVID? A Retrospective Analysis Performed by a Group of General Practitioners in a Real-Life Setting
por: Pirro, Maurizio, et al.
Publicado: (2023)

Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain
por: Impellizzeri, Daniela, et al.
Publicado: (2014)

New versus Old Oral Anticoagulants: How Can We Set the Scale Needle? Considerations on a Case Report
por: Arcadi, Francesca Antonia, et al.
Publicado: (2019)

Palmitoylethanolamide for the treatment of pain: pharmacokinetics, safety and efficacy
por: Gabrielsson, Linda, et al.
Publicado: (2016)

Palmitoylethanolamide in the Treatment of Failed Back Surgery Syndrome
por: Paladini, Antonella, et al.
Publicado: (2017)

Erratum to: Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain
por: Impellizzeri, Daniela, et al.
Publicado: (2016)

Neuroprotective Activities of Palmitoylethanolamide in an Animal Model of Parkinson's Disease
por: Esposito, Emanuela, et al.
Publicado: (2012)

INTERVENTIONS TARGETING LONELINESS AND ISOLATION AMONG LONG-TERM CARE RESIDENTS: A SYSTEMATIC REVIEW
por: Raciti, Audrieanna, et al.
Publicado: (2022)

Co-ultramicronized Palmitoylethanolamide/Luteolin in the Treatment of Cerebral Ischemia: from Rodent to Man
por: Caltagirone, Carlo, et al.
Publicado: (2015)

Add-on administration of ultramicronized palmitoylethanolamide in the treatment of new-onset burning mouth syndrome
por: Chirchiglia, Domenico, et al.
Publicado: (2019)

Palmitoylethanolamide and White Matter Lesions: Evidence for Therapeutic Implications
por: Valenza, Marta, et al.
Publicado: (2022)

An Update of Palmitoylethanolamide and Luteolin Effects in Preclinical and Clinical Studies of Neuroinflammatory Events
por: Cordaro, Marika, et al.
Publicado: (2020)

Synaptic Effects of Palmitoylethanolamide in Neurodegenerative Disorders
por: Assogna, Martina, et al.
Publicado: (2022)

The Association of Palmitoylethanolamide with Luteolin Decreases Autophagy in Spinal Cord Injury
por: Siracusa, Rosalba, et al.
Publicado: (2015)

Palmitoylethanolamide (PEA) as a Potential Therapeutic Agent in Alzheimer’s Disease
por: Beggiato, Sarah, et al.
Publicado: (2019)

Antioxidant Properties of Berberis aetnensis C. Presl (Berberidaceae) Roots Extract and Protective Effects on Astroglial Cell Cultures
por: Campisi, Agata, et al.
Publicado: (2014)

Palmitoylethanolamide dampens neuroinflammation and anxiety-like behavior in obese mice
por: Lama, Adriano, et al.
Publicado: (2022)

Administration of palmitoylethanolamide in combination with topiramate in the preventive treatment of nummular headache
por: Chirchiglia, Domenico, et al.
Publicado: (2016)

The Efficacy of Cocoa Polyphenols in the Treatment of Mild Cognitive Impairment: A Retrospective Study
por: Calabrò, Rocco Salvatore, et al.
Publicado: (2019)

ALIAmides Update: Palmitoylethanolamide and Its Formulations on Management of Peripheral Neuropathic Pain
por: D’Amico, Ramona, et al.
Publicado: (2020)

Palmitoylethanolamide counteracts reactive astrogliosis induced by β-amyloid peptide
por: Scuderi, Caterina, et al.
Publicado: (2011)

Treatment of COVID-19 olfactory dysfunction with olfactory training, palmitoylethanolamide with luteolin, or combined therapy: a blinded controlled multicenter randomized trial
por: Di Stadio, Arianna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hmk74nk8nb6li0q3dvism3hslq